8-Bromo-9-(β-D-xylofuranosyl) guanine structure
|
Common Name | 8-Bromo-9-(β-D-xylofuranosyl) guanine | ||
|---|---|---|---|---|
| CAS Number | 1212650-12-8 | Molecular Weight | 362.14 | |
| Density | N/A | Boiling Point | N/A | |
| Molecular Formula | C10H12BrN5O5 | Melting Point | N/A | |
| MSDS | N/A | Flash Point | N/A | |
Use of 8-Bromo-9-(β-D-xylofuranosyl) guanine8-Bromo-9-(β-D-xylofuranosyl) guanine is a purine nucleoside analogue. Purine nucleoside analogs have broad antitumor activity targeting indolent lymphoid malignancies. Anticancer mechanisms in this process rely on inhibition of DNA synthesis, induction of apoptosis, etc[1]. |
| Name | 8-Bromo-9-(β-D-xylofuranosyl) guanine |
|---|
| Description | 8-Bromo-9-(β-D-xylofuranosyl) guanine is a purine nucleoside analogue. Purine nucleoside analogs have broad antitumor activity targeting indolent lymphoid malignancies. Anticancer mechanisms in this process rely on inhibition of DNA synthesis, induction of apoptosis, etc[1]. |
|---|---|
| Related Catalog | |
| References |
| Molecular Formula | C10H12BrN5O5 |
|---|---|
| Molecular Weight | 362.14 |
| InChIKey | ASUCSHXLTWZYBA-SAFLGMAISA-N |
| SMILES | Nc1nc2c(nc(Br)n2C2OC(CO)C(O)C2O)c(=O)[nH]1 |